|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Net loss from discontinued operations | |||||
| Net loss from continuing operations | |||||
| Adjustments to reconcile net loss from continuing operations to net cash used in operating activities from continuing operations: | |||||
| Depreciation and amortization | |||||
| Gain on sale of property and equipment | |||||
| Impairment of goodwill and intangible assets | |||||
| Write-off of property and equipment | |||||
| Deferred income tax benefit | |||||
| Impairment of intangible asset | |||||
| Loss on write-off of property and equipment | |||||
| Unrealized gain on change in fair value of warrants classified as a liability | |||||
| Unrealized loss on change in fair value of warrants classified as a liability-warrant modification | |||||
| Transaction costs allocated to warrant liabilities | |||||
| Loss on issuance of warrants | |||||
| Shares issued Spindle earnout | |||||
| Stock-based compensation | |||||
| Bad debt expense | |||||
| Change in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses, other current assets and deposits | |||||
| Accounts payable and accrued liabilities | |||||
| Deferred revenue | |||||
| Net cash used in operating activities | |||||
| Deferred revenue | |||||
| Net cash used in operating activities from continuing operations | |||||
| Cash flows from investing activities: | |||||
| Cash paid for Spindle asset purchase | |||||
| Proceeds from sale of property and equipment | |||||
| Purchase of property and equipment | |||||
| Net cash used in investing activities | |||||
| Net cash used in investing activities from continuing operations | |||||
| Cash flows from financing activities: | |||||
| Net proceeds from issuance of common stock | |||||
| Capitalized offering costs | |||||
| Net proceeds from issuance of common stock and pre-funded warrants | |||||
| Net cash provided by financing activities from continuing operations | |||||
| CASH FLOWS FROM DISCONTINUED OPERATIONS | |||||
| Cash used in operating activities | |||||
| Cash provided by investing activities | |||||
| Net cash used in discontinued operations | |||||
| Net decrease in cash, cash equivalents and restricted cash | |||||
| Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Less: cash and cash equivalents of discontinued operations | |||||
| Cash, cash equivalents and restricted cash of continuing operations at end of period | |||||
| Supplemental Disclosures of Cash Flow Information: | |||||
| Cash paid during period for income taxes | |||||
| Non-cash investing and financing activities: | |||||
| Common stock issued for Spindle asset purchase | |||||
| Deferred tax liability for Spindle asset purchase | |||||
| Leased assets obtained in exchange for new operating lease liabilities | |||||
| Transaction costs included in accounts payable | |||||
| Deemed dividend warrant modifications | |||||
| Warrants issued, cashlessly | |||||
| Property and equipment acquired and included in accounts payable | |||||
Loading...